STK11 and ovarian carcinoma: To assess whether loss of LKB1-AMPK signalling can affect ovarian cancer spheroid sensitivity to platinum agents, adherent cell and spheroids transfected with STK11 or PRKAA1 siRNA were treated subsequently with carboplatin.